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Abstract 
Culinary herbs and spices (CHS) are known primarily as flavour enhancers, and it is now well 
established that they possess bioactive properties that indicate that these foods may have a role to 
play in the prevention of non-communicable chronic diseases (CNCDs). Human studies are now 
beginning to provide insights into the significance of the potential health benefits of CHS in a dietary 
context, particularly concerning their antioxidant and anti-inflammatory properties and their impact 
on glucose homeostasis, appetite and the consumption of low/reduced fat, salt and sugar foods.  
However, these studies have also identified a number of factors that are very pertinent to furthering 
understanding of how CHS can be used for the maintenance of health and the prevention of CNCDs. 
The challenge for the next phase of studies will be how to incorporate, successfully, these factors into 
study methodology for investigating the preventative benefits of these foods.   
Keywords: culinary herbs and spices, bioactive properties, chronic non-communicable diseases, 
human studies 
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Introduction 
There is a significant body of work concerning the use of culinary herbs and spices (CHS) beyond their 
use as flavour enhancing foods. History provides evidence of their use for medicinal purposes in 
Ancient China, Greece, India and Rome for the treatment of cancer, jaundice, gastro-intestinal 
infections, mouth ulcers, asthma, and chest problems, as well as to boost memory and cognitive 
performance(1). More recently, research has focussed on bioactive properties that indicate that these 
foods might have a role to play in the prevention of chronic non-communicable diseases (CNCDs) 
including cardiovascular disease, cancer and type 2 diabetes (T2D)(2-5). These bioactive properties, 
which include their antioxidant, anti-inflammatory and anti-cancer activities, and their effect on 
glucose and lipid metabolism and food intake, are known to be conferred on them by their 
phytochemical constituents particularly, but not limited to, those that are polyphenolic(6-9).  
What can this growing body of evidence concerning the bioactive properties of CHS tell us about their 
significance in relation to CNCDs prevention, specifically in a dietary context?  Work carried out in vitro 
provides valuable insights into their mechanisms of action. However, despite some addressing  how 
they are consumed, the amounts used and processes that impact on them post-consumption, such 
studies are limited as they are unable to take into consideration other factors that are key to CHS 
bioactivity in vivo(6,10).  Animal studies can begin to shed light on their action in vivo but are small in 
number and are limited due to species differences (5,11). To answer the question above it is necessary 
to consider in vivo studies done using healthy humans, or those at risk of developing CNCDs. However, 
it is important that such studies are focussed on the benefits of whole CHS, rather than their 
phytochemical constituents, and have considered intake levels that are palatable and reflect habitual 
use in food preparation and consumption.   
Culinary herbs and spices: their antioxidant and anti-inflammatory activities in vivo 
The antioxidant and anti-inflammatory properties of CHS are well established in vitro.  However, the 
findings from human studies are mixed (Table 1). One CHS study by Percival et al., (12) investigated 
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their bioavailability in healthy humans by measuring antioxidant capacity and also their effect, ex vivo, 
on DNA damage and markers of inflammation post consumption of individual CHS (black pepper, 
cinnamon, clove, cumin, ginger, oregano, paprika, rosemary, turmeric and sage) in capsule form for 7 
days.  The amounts per capsule were based on those typically consumed. Although, in an 
acknowledgement of the challenges of obtaining accurate intake data, to determine typical 
consumption it was assumed that all foods consumed per day were seasoned. Thus, the authors noted 
that the amounts used were likely over-estimations. Interestingly, no increases in antioxidant capacity 
were detected in the subjects’ sera which was attributed to the marked intra/inter individual 
variability between the subjects’ samples. These results suggest that the use of antioxidant capacity 
as a biomarker of antioxidant effect, in vivo, needs to be treated with caution. In contrast, a number 
of the CHS namely paprika, rosemary, ginger, heat-treated turmeric, sage and cumin protected 
peripheral blood mononuclear cells taken from the volunteers against DNA damage ex vivo. 
Expression ex vivo of cytokine markers of inflammation, namely TNF-α, IL-1α and IL-6 mRNA was also 
decreased. However, those with the highest antioxidant capacities (clove, rosemary and turmeric) did 
not significantly decrease the expression of all three inflammatory markers (only TNF-α was affected).  
It was ginger, the CHS with one of the lowest antioxidant capacities, which stood out as the only CHS 
to decrease the expression of all three markers. Thus, suggesting that the anti-inflammatory activity 
of at least some CHS may be independent of their ability to act as antioxidants. This study provides 
evidence of the potential benefit of CHS on DNA damage and inflammation, which both play a 
significant role in the aetiology of CNCDS. One may argue that the fact that the responses are ex vivo 
is a limitation. However, being able to demonstrate these significant responses in vivo would be 
extremely difficult, if not unlikely, as the subjects used were healthy and thus not in an inflammatory 
state of a magnitude similar to that simulated ex vivo.  A study in which rosemary extract (77.7mg) 
given in capsule form for 21 days appears to add credence to this view (13). It used healthy volunteers 
who were either smokers or had a family history of symptomatic atherosclerosis, and thus could be 
considered to be at risk.  Although non-significant decreases in serum TNF-α and C-reactive protein 
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(CRP) were observed, the levels of plasminogen activator inhibitor type 1 (PAI-1), whose expression 
has been shown to be stimulated by TNF-α and IL-6(14), decreased significantly along with the rate of 
arterial endothelial dysfunction (ED). It may be that the non-significant decreases in the inflammatory 
markers were sufficient to result in this change in PAI-1.  Although both studies provide some evidence 
of the protective effect of individual CHS, they also highlight the difficulties of demonstrating in vitro 
bioactive properties of CHS in vivo.  
In a study by Li et al., (15), CHS were not given individually but as part of a non-herb food, namely 
hamburger meat. They investigated the effects of a high antioxidant CHS blend, containing black 
pepper, clove, cinnamon, garlic, ginger, oregano, paprika and rosemary, combined with the 
hamburger meat on levels of malondialdehyde in healthy human volunteers. Malondialdehyde is a 
product of lipid oxidation which can form DNA adducts, and thus may have a role to play in 
atherogenesis and carcinogenesis. In designing the study to include CHS seasoned hamburger meat 
the authors recognised that CHS are normally consumed with other foods. Compared to the study 
discussed above (12), the amount consumed in one take was high (11.3g) however, palatability of the 
spiced hamburger was not significantly affected. Consumption of the spiced hamburger resulted in a 
trend to decrease plasma malondialdehyde over a six hour period following consumption. In addition, 
urinary malondialdehyde levels decreased significantly following the consumption of the spiced 
burger. The effect of a similar CHS blend (modified to ensure it was appropriate for the foods to which 
it was combined – dessert biscuit, coconut chicken and cheese bread) on post-prandial changes to 
plasma antioxidant capacity in healthy subjects who were overweight has also been investigated (16).  
The total amount used was high at 14g but again palatability was not affected significantly. Unlike the 
findings of Percival et al., (12), the study reported increases in plasma antioxidant capacity suggesting 
that as with (15) the blend worked to improve antioxidant status and ultimately confer protection via 
this action. However, the increases were not consistent and appeared to be dependent on the 
hydrophilicity and lipophilicity of the antioxidant compounds, and the type of assay used. Some 
antioxidant assays are affected by any compound that possesses reducing power which raises 
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questions about their usefulness with regards to the determination of antioxidant activity in vivo (17,18). 
Overall, these CHS blend studies are of significance as they provide more evidence of the protective 
effect of CHS in dietary contexts, albeit in controlled settings. However, to provide further insights 
concerning benefit, and how they confer it, the effect of these and other CHS blends combined with 
non-herb foods/meals for periods that reflect habitual consumption needs to be investigated. 
Culinary herbs and spices: their effect of on glucose homeostasis:  
Another major focus of the potential benefits of CHS is their effect on glucose homeostasis as some 
have been shown to possess insulin-like activities via their polyphenolic constituents in vitro (5).  These 
properties have led to a plethora of studies in which the therapeutic potential of CHS in the 
management of T2D has been assessed (5). These studies have formed the basis for investigating their 
preventative potential with regards the development of T2D (Table 2).  For example, the impact of 
cinnamon on post-prandial glucose in healthy and pre-diabetic subjects has been the focus of much 
attention. In their study on the effects of cinnamon on glucose tolerance, Solomon and Balnnin (2007) 
(19) reported that following the ingestion of capsulated cinnamon (5g) by lean healthy male volunteers, 
their total plasma glucose response to oral glucose was decreased. In addition, their insulin sensitivity 
was improved. However, the authors acknowledged that the amount given far exceeded what is 
typically consumed (although the subjects did not report any problems with ingestion). Markey et al., 
(2011) (20) investigated the effect of a smaller amount of powdered cinnamon spice in capsules (3g in 
total) taken directly before and after the consumption of a high fat meal, and reported no effect on 
gastric emptying, glucose homeostasis, blood lipid levels, lipid peroxidation and vascular function, 
specifically arterial stiffness. The relatively low amount of cinnamon used, an amount that is closer to 
what is typically consumed, based on the estimations provided by (12), could be identified as the major 
contributor to the lack of effect. However, the authors identified other factors may have influenced 
the results including: the subjects not being in a hyperglycaemic nor a hyperlipidaemic state; and the 
meal having a high, but not sufficient, fat content to give rise to changes in vascular function that were 
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significant. How influential these factors are is unclear as the subjects were healthy and they 
consumed the high fat meal once in a 15 minute period. However, the authors’ suggestions do 
highlight the challenge of simulating real world food consumption in a controlled environment.  
In pre-diabetic overweight and obese subjects, cinnamon in capsule form (250mg twice a day for 12 
weeks, which based on data from (11) is approximately half of what is typically consumed) was shown 
to decrease fasting blood glucose (FBG). However, insulin levels were unchanged (21). The decrease in 
fasting glucose was associated with changes in some but not all of the markers of oxidative stress 
measured which highlights again the issue of inconsistency concerning measures of antioxidant effect. 
However, there was a significant positive correlation between changes in FBG and malondialdehyde.  
In fact, the antioxidant effect essentially mirrored that of FBG – a relationship which might be 
interpreted as providing supporting evidence of impaired FBG causing oxidative stress in obesity (22) 
which is diminished by cinnamon. Similar findings, concerning the effect of cinnamon on FBG in pre- 
diabetic overweight and obese subjects, have been reported in a more recent study (23).   
Bearing in mind the importance of the dietary context, it is necessary to establish the impact the CHS 
when consumed with a meal on blood glucose. A number of studies show that CHS, specifically 
cinnamon, turmeric and CHS blends, all consumed as part of a meal or beverage, lower post-prandial 
blood glucose (24-26). The results of some of these studies indicate that dose may be an important factor 
when it comes to efficacy. For example, 6g of cinnamon consumed with a meal (rice pudding) was 
reported to decrease post-prandial blood glucose. In contrast, 1, 3, and 4g of cinnamon consumed 
with a similar meal were reported as having no effect when consumed with a meal (24,27,28). However, 
the 1 and 3g doses resulted in a decrease in insulin (the decrease was significant for the higher dose) 
Furthermore, the 3g dose resulted in a significant increase in the levels of glucagon-like peptide 1 
(GLP-1), a gastrointestinal peptide hormone known to delay gastric emptying and stimulate glucose 
dependent insulin secretion (29,30). Other studies point to the use of CHS in combination, and not dose, 
as a requirement for efficacy. Skulas-Ray et al., (15) reported that post-consumption of foods spiced 
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with black pepper, cinnamon, cloves, ginger, oregano, paprika, rosemary and/or turmeric significantly 
decreased post-prandial insulin and triglyceride responses. The meals had no effect on post-prandial 
glucose but the small glycaemic response to the un-spiced control meal is argued to have accounted 
for this effect. Furthermore, Hadar et al., (26) reported that a polyphenol rich curry (the Polypspice 
curry) prepared using a CHS blend (of 6 and 12g in total) and vegetables had a significant dose-
dependent effect in decreasing blood glucose in healthy subjects. This effect is thought to involve GLP-
1 as a subsequent study using the Polyspice curry reported that this hormone was increased in a dose-
dependent manner (31).  
The single CHS studies have their place in helping to establish whether or not CHS can confer benefit 
but it is the combined CHS studies, specifically, that are extremely informative as they recognised the 
need to investigate the effects of CHS in a ‘real life dietary context’. They also went one step further 
as they determined the composition and doses of the blend based on typical consumption. 
Furthermore, they highlight that the form and composition of the CHS blends and, as with some of 
the single CHS studies (19), the composition of the test meals are factors that cannot be ignored when 
investigating efficacy. These factors, therefore, need to be taken into consideration in future studies, 
possibly by using a variety of test meals as stated earlier. Finally, for both the single and combined 
CHS studies in which CHS were consumed as part of a meal, the choice of subjects may also be an 
influencing factor on the impact of CHS on glucose homeostasis.  Subjects were either overweight (16), 
normal (23, 25) or normal to overweight (25-27). In light of literature that points to body composition 
influencing the efficacy of plant derived foods, and the large inter-individual variations in glycaemic 
response reported for (26), it is tempting to speculate that the subjects who were overweight were in 
a state of insulin resistance, which resulted in greater responses.  
Overall, human studies indicate that CHS, particularly those involving the consumption of CHS blends, 
in amounts typically used as part of a meal, are able to influence glucose homeostasis possibly via 
actions on glucose regulating hormones, insulin and GLP-1. However, the use of such blends in long-
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term studies is needed to determine the true significance of such effects in relation to the 
development of T2D.  
Culinary herbs and spices: their effect on appetite 
Another activity possessed by CHS which could confer protection is their effect on appetite, and food 
intake, for the purpose of weight maintenance following weight loss (32) (Table 2). The bases for this 
work are their sensory properties and their impact on food choice and energy intake. It has been 
theorised that such foods may give rise to cephalic phase responses involving the secretion of gut 
hormones, including glucagon-like peptide 1 (GLP-1) and ghrelin, which have been shown to alter 
appetite and metabolism via their satiety enhancing/anorexigenic and appetite stimulating/orexigenic 
effects respectively (33,34).  Other purported mechanisms include their thermogenic effects via sensory 
stimulation and the action of their constituent polyphenols and flavour compounds on digestive 
processes (32). Black pepper, cinnamon, ginger, horseradish and saffron have all been investigated for 
their appetitive effects based on one or more of the mechanisms listed above. However, the findings 
are mixed and thus far from definitive (25,32,35,36).  
Another CHS, which has been the focus of this area of research, is red chilli pepper due to its 
constituent capsaicin. Capsaicin is responsible primarily for the pungent aroma and taste of this CHS, 
and, via the activation of the central nervous system located ‘capsaicin receptor’, is reported to 
increase lipid oxidation and decrease adipose tissue (9,37-40).   A systematic review of human studies (41) 
in which red chilli pepper is consumed on its own, in capsule form, or combined with non-herb 
foods/meals (including soups and high carbohydrate/fat meals) identified studies that reported 
increases in energy expenditure (EE), decreases in appetite and/or energy intake. A small number of 
these studies suggested that the increase in EE equated to approximately between 50 - 100kcal/day; 
the upper range for a 100kg person (42,43). Whether these estimated changes are of significance in 
terms of weight loss is not clear but one study concluded that a 50kcal/day increase would produce 
levels of clinically significant weight loss over a 1-2 year period (43).  
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Form and amount are influential with respect to outcome. Regarding the former, red chilli pepper 
consumed orally generally resulted in greater increases in fat oxidation and energy expenditure, and 
greater decreases in energy intake, than when taken in capsule form.  Thus, suggesting that oral 
stimulation enhances the effect of this CHS (44).  Effective amounts also vary and reflect the impact of 
subjects who were users or non-users and the variations in global/cultural differences in the amounts 
that are consumed (41,45). Such variations have raised questions as to whether recommendations to 
increase the intake of red chilli pepper can realistically be sustained. This is a salient point, especially 
for those who consume very little if any CHS and are likely to find red chilli pepper extremely pungent 
and thus unpalatable (a factor that can in itself suppress appetite) (41).    
More recent work on the CHS blend containing Polyspice curry provides further support for the role 
of CHS in modulating appetite. At the same amounts shown to decrease post-prandial glucose and 
increase GLP-1 (26,31), the meal is reported to significantly suppress hunger and the desire to eat 
compared to the unseasoned control (46). However, this suppression was not dose-dependent and had 
no effect on ghrelin. Although promising, currently, this result can do no more than suggest that the 
Polyspice curry might be of use in the maintenance of weight following weight loss. For more definitive 
data, studies of the effect of meals seasoned with CHS in the context of habitual food intake are 
needed (46). 
 
Culinary herbs and spices: the conferring of protection via their role as flavour enhancers 
for low fat, low sugar and low salt foods 
Studies on the potential benefit of CHS via their role as flavour enhancers involve a very different 
approach to work focussed on their bioactive properties. High intakes of fat (especially saturated fat), 
salt and/or sugar are associated with increased risk of developing CNCDs (47-51).  Thus, strategies to 
help consumers make healthy choices with regards their diet include the use of low/reduced fat, salt 
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and sugar foods. However, fat, sugar and salt are major flavour contributors, and thus drivers of 
acceptance and ultimately consumption.  
Culinary herbs and spices are used in the preparation of food primarily to enhance their flavour, and 
they are of little to no calorific value. Based on these attributes, a small but growing amount of 
research (52-60) suggests that a variety of CHS may be effective in increasing the overall liking of 
reduced/low fat, salt and sugar foods. This work also suggests that CHS may be successful in reducing 
the addition of salt to low salt foods such as vegetables. Considering their bioactive properties, the 
successful use of CHS in such a capacity could have a dual benefit. However, despite the suggestion of 
efficacy, collectively these studies have identified a number of factors that need to be considered 
before such a strategy can be implemented successfully. These factors include:  
 The flavour profile and intensity of the test foods/meals used 
 The nutrient/phytochemical composition of the test foods/meals used  
 Familiarity with the CHS 
 Cultural influences on the choice and amount of CHS used 
 The impact of the amount and type of CHS used on palatability  
 The form/preparation of the test meal – freshly prepared or canned or frozen and re-heated, 
and the inclusion of non-CHS ingredients 
 The duration of exposure to foods with CHS added 
 The influence of CHS when part of a broader strategy to reduce fat, salt and sugar intake 
Interestingly some of these factors have also been highlighted above in the discussion above 
concerning the bioactive properties of CHS which indicates that they (the factors) are very pertinent 
to understanding more fully how CHS can be used effectively in maintaining health and preventing 
CNCDs.  
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Conclusion 
Studies carried out in vitro on CHS have their place concerning the elucidation of their mechanisms of 
action, and single studies have proven to be useful in identifying benefits of individual CHS in humans. 
However, in a dietary context, the key to establishing definitively what their significance is lies in 
studies in which their habitual use, specifically how they are used and consumed typically, is taken 
into consideration. Human studies using such an approach have provided some compelling evidence 
that CHS are of benefit to the maintenance of health at amounts that are typically consumed. These 
studies have, via their findings, also highlighted the need to address a number of factors. These include 
nutrient and phytochemical composition of the test meal, the type of subjects in relation to risk, levels 
of habitual consumption, palatability and biomarkers of effect.  These factors are likely to be integral 
to furthering understanding of the significance of the benefits demonstrated thus far. The challenge 
for the next phase of investigations, into the preventative benefits of these foods, will be to 
incorporate, successfully, these factors into study methodology. 
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Table 1: Amounts of culinary herbs and spices (CHS) associated with effects that may confer prevention against the development of chronic non-communicable diseases 
(CNCDs) – antioxidant and anti-inflammatory studies 
 
Culinary herbs and spices Amount consumed Form Bioactive properties/potential 
benefit 
Reference 
Clove 0.3g/day for 7 days 
 
Capsule Decreased expression of 
inflammatory markers ex vivo 
 
11 
 
Cinnamon 250mg, twice a day for 12 
weeks 
 
Dried aqueous extract Improvement in plasma 
oxidative stress markers FRAP 
and plasma thiol; decrease in 
plasma malondialdehyde (in 
pre-diabetic, overweight or 
obese subjects) 
 
21 
Cumin 2.8g/day for 7 days Capsule Protection against DNA strand 
breaks ex vivo 
11 
Ginger 
 
 
 
2.8g/day for 7 days capsule 
 
Protection against DNA strand 
breaks and decreased 
expression of inflammatory 
markers ex vivo 
11 
Paprika 1.7g/day for 7 days 
 
Capsule 
 
Protection against DNA strand 
breaks ex vivo 
11 
 
Rosemary 
 
 
 
 
2.8g/day for 7 days 
 
 
 
 
 
77.7mg per day for 21 days 
 
 
 
 
 
Capsule 
 
 
 
 
 
Extract in tablet form 
 
 
 
 
 
Protection against DNA strand 
breaks and decreased 
expression of inflammatory 
markers ex vivo 
 
Decreased PAI-1 activity and 
improvement in endothelial 
dysfunction 
 
11 
 
 
 
 
 
12 
 
 
 
 
 
17 
 
 
 
  
 
 
 
Sage 1.7g/day for 7 days Capsule Protection against DNA strand 
breaks ex vivo 
11 
Turmeric 0.3g/day for 7 days 
 
 
 
 
Capsule and heat treated Protection against DNA strand 
breaks and decreased 
expression of inflammatory 
markers ex vivo 
11 
 
 
CHS blend Black pepper – 0.7g 
Clove – 0.5g 
Cinnamon – 0.5g 
Garlic  (powdered)- 1.5g 
Ginger – 1.2g 
Oregano – 3.0g 
Paprika – 3.4g 
Rosemary – 0.5g 
 
 
Ground (with the exception of 
garlic) blend used to season 
hamburger meat (250g raw 
weight) 
 
Reduction in plasma and urine  
malondialdehyde vs. control  
 
14 
CHS blend Black pepper – 0.91g 
Cloves - 0.61g 
Cinnamon – 0.61g 
Garlic – 1.81g 
Ginger – 1.51g 
Oregano – 2.26g 
Paprika – 2.85g 
Rosemary – 0.61g 
Turmeric – 2.79g 
Part of a CHS blend used to 
season dessert biscuits, coconut 
chicken and/or cheese bread 
Increase in hydrophilic ORAC 
levels in plasma in healthy, 
overweight subjects 
 
15 
Unless otherwise stated, healthy, normal weight subjects were used. Abbreviations: ORAC - oxygen radical absorbance capacity; FRAP - ferric reducing antioxidant power 
 
Table 2: Amounts of culinary herbs and spices (CHS) associated with effects that may confer prevention against the development of chronic non-communicable diseases 
(CNCDs) – post-prandial, fasting blood glucose and appetite studies 
18 
 
 
Culinary herbs and spices Amount consumed Form Bioactive properties/potential 
benefit 
Reference 
Black pepper Approx. 4.4g  Black pepper flavored water Lowered hunger and desire to 
eat; increased satiety and 
fullness; no effect on post-
prandial glucose and insulin; no 
effect on anorexigenic 
hormones, PYY and GLP-1  
36 
CHS blend Black pepper – 0.91g 
Cloves - 0.61g 
Cinnamon – 0.61g 
Garlic – 1.81g 
Ginger – 1.51g 
Oregano – 2.26g 
Paprika – 2.85g 
Rosemary – 0.61g 
Turmeric – 2.79g 
Part of a CHS blend used to 
season dessert biscuits, coconut 
chicken and/or cheese bread 
No change in post-prandial 
glucose, decrease in post-
prandial insulin and triglyceride 
response to meal in healthy, 
overweight subjects  
 
15 
CHS blend Cayenne pepper (powder) – 
0.5g and 1g 
Cinnamon (powder) – 0.25g 
and 0.5g 
Clove (powder) – 0.25g and 
0.5g 
Coriander seeds (powder) – 1g 
and 2g 
Cumin seeds (powder) 1g and 
2g 
Garlic (fresh) – 10g and 20g 
Ginger (fresh) – 10g and 20g 
Indian gooseberry ‘amla’ 
powder – 1g and 2g 
Turmeric (powder) – 2g and 4g 
Curry (also included tomato 
puree, onions and aubergine ) 
Dose-dependent decrease in 
post-prandial glucose and GLP-
1; decrease in appetite. 
26, 31 
Cinnamon 5g 
 
 
Capsule 
 
 
Decrease in total plasma 
glucose responses to oral 
19 
 
 
19 
 
 
 
 
250mg, twice a day for 12 
weeks 
 
 
250mg, twice a day for 8 weeks 
 
 
 
 
6g 
 
 
 
3g 
 
 
 
 
60ml extract equivalent to 6g 
of dry weight 
 
 
 
 
 
 
 
Dried aqueous extract 
 
 
 
Spray dried aqueous extract 
 
 
 
 
Consumed with rice pudding 
(300g) 
 
Consumed with rice pudding 
(300g) 
 
 
 
 
Spice-based beverage 
glucose and improvement in 
insulin sensitivity. 
 
Decrease in fasting blood 
glucose, no change in fasting 
insulin in pre-diabetic, 
overweight or obese subjects 
 
Decrease in fasting glucose and 
fasting insulin in pre-diabetic 
subjects 
 
 
Post-prandial glucose and 
gastric emptying lowered 
 
No change in post-prandial 
glucose; decrease in post-
prandial insulin levels; increase 
in GLP-1, no effect on appetite 
 
 
Lowered increment in early 
blood glucose compared to 
control 
 
 
 
 
 
22 
 
 
 
23 
 
 
 
 
24 
 
 
27 
 
 
 
 
 
25 
Red chilli pepper 0.3g – approx. 10g 
 
 
 
 
 
 
 
 
Ground red chili pepper added to 
meal or drink 
 
 
 
 
 
 
 
Preoccupation with food and 
desire to eat decreased but 
only for those who were 
nonusers of red pepper 
 
Increase in desire to eat sweet 
foods, decrease in desire to eat 
hot foods, no effect on energy 
or food intake 
41 
20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Approx. 0.4g – approx. 2g 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Capsule containing ground red 
chili pepper  
No effect on desire to eat, 
fullness, prospective food 
intake or hunger 
 
Increase/trend to increase in 
GLP-1, trend towards a 
decrease in ghrelin, no change 
to PYY or satiety 
 
Increase in energy expenditure 
and carbohydrate and fat 
oxidation 
 
 
  
Increase in satiety and 
carbohydrate intake, decrease 
in hunger and fat intake 
 
Increase in fullness and satiety 
during negative energy balance 
and decrease in hunger during 
positive energy balance 
Turmeric 220ml extract Spice-based beverage Lowered increment in early 
blood glucose compared to 
control. Increased plasma PYY 
and lowered desire to eat and 
prospective food consumption 
(how much food the subject 
thought they could eat when 
asked). 
25  
CHS blend Cayenne pepper (powder) – 
0.5g and 1g 
Cinnamon (powder) – 0.25g 
and 0.5g 
Curry (also included tomato 
puree, onions and aubergine ) 
Dose-dependent decrease in 
post-prandial glucose and GLP-
1; decrease in appetite. 
26, 31, 46 
21 
 
Clove (powder) – 0.25g and 
0.5g 
Coriander seeds (powder) – 1g 
and 2g 
Cumin seeds (powder) 1g and 
2g 
Garlic (fresh) – 10g and 20g 
Ginger (fresh) – 10g and 20g 
Indian gooseberry ‘amla’ 
powder – 1g and 2g 
Turmeric (powder) – 2g and 4g 
Unless otherwise stated, healthy subjects were used. Abbreviations: GLP-1 – glucagon-like peptide 1; PYY – peptide tyrosine tyrosine 
 
